tradingkey.logo
tradingkey.logo
Search

Aurinia Pharmaceuticals Inc

AUPH
Add to Watchlist
15.730USD
-0.480-2.96%
Close 11-13 16:00(ET)
2.11BMarket Cap
7.06P/E TTM

Today

-2.96%

5 Days

-4.43%

1 Month

-5.30%

6 Months

-0.69%

Year to Date

-1.38%

1 Year

+2.48%

Key Figures

16.270Open
16.440High
61.06KVolume
7.06P/E TTM
14.12P/E Dynamic
--Dividend TTM
0.05%Turnover Ratio
16.210Prev. Close
15.740Low
970.89KTurnover
366.68P/E Static
3.43P/B
0.00%Div Yield TTM
48.54%ROA
19.25052wk High
0.06Volume Ratio
5.75MNet Profit
134.00MShares
2.2289EPS TTM
1.43Beta
64.98%ROE
13.52052wk Low
4.32%Amplitude
90.08%Gross Margin
2.11BMarket Cap
0.59Reward/Risk
2.23%Risk Rate
More news coming soon, stay tuned...

Aurinia Pharmaceuticals Inc's Score

-0.02vs previous score
Forecast7.71
Financial Health8.97
Technical2.82
Valuation Dimensions7.65
Institutional Confidence5.00
Risk Assessment7.62

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
18.286Target Price
+9.82%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy11111111
Buy44333333
Hold22333333
Sell00000000
Strong Sell00000000

Aurinia Pharmaceuticals Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
0.24/0.22
Revenue / Forecast
83.70M/83.69M

Aurinia Pharmaceuticals Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolAUPH
Number of employees130
CountryCanada

Ownership

ShareholdersProportion
Tang Capital Management, LLC9.51%
BlackRock Institutional Trust Company, N.A.5.12%
ILJIN SNT Co., Ltd.5.08%
New Enterprise Associates (NEA)3.09%
Shareholder TypesProportion
Hedge Fund18.10%
Investment Advisor/Hedge Fund16.56%
Investment Advisor15.90%
Corporation5.08%

FAQs

What is the current price of Aurinia Pharmaceuticals Inc (AUPH)?

The current price of Aurinia Pharmaceuticals Inc (AUPH) is 15.73.

What is the symbol of Aurinia Pharmaceuticals Inc?

The ticker symbol of Aurinia Pharmaceuticals Inc is AUPH.

What is the 52-week high of Aurinia Pharmaceuticals Inc?

The 52-week high of Aurinia Pharmaceuticals Inc is 19.25.

What is the 52-week low of Aurinia Pharmaceuticals Inc?

The 52-week low of Aurinia Pharmaceuticals Inc is 13.52.

What is the market capitalization of Aurinia Pharmaceuticals Inc?

The market capitalization of Aurinia Pharmaceuticals Inc is 2.11B.

Is Aurinia Pharmaceuticals Inc (AUPH) currently rated as Buy, Hold, or Sell?

According to analysts, Aurinia Pharmaceuticals Inc (AUPH) has an overall rating of Buy, with a price target of 18.29.

What is the Earnings Per Share (EPS TTM) of Aurinia Pharmaceuticals Inc (AUPH)?

The Earnings Per Share (EPS TTM) of Aurinia Pharmaceuticals Inc (AUPH) is 2.23.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.